Free tool
FAERS Monitor: Tryvio
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 217686 or its brand name (Tryvio, Aprocitentan). Reports on generic versions are filed under their own applications.
Reports
22
Serious
13
59% of reports
Hospitalization
5
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea3
- malaise3
- heart rate increased2
- oedema peripheral2
- peripheral swelling2
- weight increased2
- abdominal discomfort1
- anaemia1
- aortic valve replacement1
- arthralgia1
- asthenia1
- atrial fibrillation1
- blood sodium decreased1
- blood urine1
- breast cancer1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2021 | 1 |
| 2025 | 11 |
| 2026 | 10 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,137 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood urine | 1 | 992.7 | 146.1 | 247 |
| aortic valve replacement | 1 | 763.8 | 112.5 | 190 |
| blood sodium decreased | 1 | 50.7 | 7.5 | 12 |
| heart rate increased | 2 | 19.3 | 5.1 | 19 |
| oedema peripheral | 2 | 15.7 | 4.2 | 15 |
| peripheral swelling | 2 | 12.4 | 3.3 | 11 |
| breast cancer | 1 | 10.3 | 1.5 | 2 |
| atrial fibrillation | 1 | 9.8 | 1.4 | 2 |
| weight increased | 2 | 8.5 | 2.3 | 7 |
| malaiseSignal | 3 | 6.5 | 2.3 | 9 |
| abdominal discomfort | 1 | 5.7 | 0.8 | 1 |
| dyspnoeaSignal | 3 | 5.1 | 1.8 | 6 |
| anaemia | 1 | 5.0 | 0.7 | 0 |
| asthenia | 1 | 2.5 | 0.4 | 0 |
| arthralgia | 1 | 2.3 | 0.3 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.